Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 13/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 7/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.37 |
| ▸ | DPP4 | P27487 | 5/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.34 |
| ▸ | FAP | Q12884 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26606339 | 0.83 | GSR (0.53) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL27005 | 0.83 | GSR (0.53) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL13084137 | 0.76 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL13592271 | 0.76 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL14215018 | 0.76 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL331322 | 0.75 | GSR (0.33) | GSRRNPEPCPB2 | |
| SCHEMBL2058457 | 0.75 | FOLH1 (0.36) | GSRRNPEPCPB2 | |
| SCHEMBL5501937 | 0.73 | GSR (0.55) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL31397604 | 0.73 | RNPEP (0.36) | RNPEP | |
| SCHEMBL7294151 | 0.72 | GSR (0.53) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113412280-A | Activity modulating antibodies | 海德格霍格有限公司 | 2021-09-17 | — | — | CN | disclosed |
| CN-113330035-A | Anti-beta 1integrin humanized antibody and pharmaceutical composition for treating cancer comprising the same | SG医疗株式会社 | 2021-08-31 | — | — | CN | disclosed |